Related Experiment Video

Updated: Sep 4, 2026

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

An aspirin a day to prevent prematurity

B M Sibai1

  • 1Department of Obstetrics/Gynecology, University of Tennessee, Memphis, Memphis.

Clinics in Perinatology
|June 1, 1992
PubMed

Insights

Low-dose aspirin can help prevent preterm birth caused by fetal growth restriction and preeclampsia. This treatment is effective for high-risk pregnancies by balancing prostacyclin and thromboxane levels.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Pharmacology

Background:

  • Intrauterine fetal growth retardation and preeclampsia are major causes of preterm birth globally.
  • A key factor in these conditions is an imbalance between prostacyclin and thromboxane A2 production.
  • This imbalance affects vascular function during pregnancy.

Purpose of the Study:

  • To evaluate the efficacy and safety of low-dose aspirin in preventing preeclampsia and fetal growth retardation.
  • To assess the impact of low-dose aspirin on prostacyclin and thromboxane A2 balance.
  • To determine the role of low-dose aspirin in reducing preterm birth.

Main Methods:

  • Review of randomized and uncontrolled trials.
  • Analysis of existing literature on low-dose aspirin in pregnancy.
  • Assessment of prostacyclin and thromboxane A2 levels in relation to aspirin use.

Main Results:

  • Low-dose aspirin appears to correct the functional imbalance between prostacyclin and thromboxane A2.
  • This leads to an improved prostacyclin to thromboxane ratio.
  • Trials suggest efficacy in reducing preterm birth in selected high-risk pregnancies.

Conclusions:

  • Low-dose aspirin is a potentially effective intervention for preventing preeclampsia and fetal growth retardation.
  • The drug helps restore a healthier balance of key vascular compounds.
  • It offers a strategy to reduce preterm birth in specific high-risk obstetric populations.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...